| US5504074A (en) | 1993-08-06 | 1996-04-02 | Children's Medical Center Corporation | Estrogenic compounds as anti-angiogenic agents |
| US6908910B2 (en) | 1993-08-06 | 2005-06-21 | The Children's Medical Center Corporation | Estrogenic compounds as anti-mitotic agents |
| US7772220B2 (en)* | 2004-10-15 | 2010-08-10 | Seo Hong Yoo | Methods and compositions for reducing toxicity of a pharmaceutical compound |
| ATE406907T1 (en) | 1998-10-28 | 2008-09-15 | Cornell Res Foundation Inc | METHODS FOR REGULATION OF ANGIOGENESIS AND VASCULAR INTEGRITY USING TRK RECEPTOR LIGANDS BDNF, NT-3 AND NT-4 |
| US7087592B1 (en) | 1999-08-23 | 2006-08-08 | Entre Med, Inc. | Compositions comprising purified 2-methoxyestradiol and methods of producing same |
| PT1214077E (en)* | 1999-09-21 | 2004-05-31 | Inst Cardiologie Montreal | LOCAL LIBRARY OF 17-BETA ESTRADIOL TO IMPROVE THE VASCULAR FUNCTION OF ENDOTHELIA IN THE SEQUENCE OF VASCULAR WOUNDS |
| AU1480301A (en)* | 1999-11-09 | 2001-06-06 | Pharmacia Corporation | Methods for treating, inhibiting or preventing pathogenic change resulting from vascular injury with an aldosterone antagonist |
| DE19957342A1 (en)* | 1999-11-29 | 2001-05-31 | Gruenenthal Gmbh | Treatment of interleukin (IL)-12 mediated illnesses comprises simultaneous administration of thalidomide or analogue and antiinflammatory cytokine |
| US7182953B2 (en)* | 1999-12-15 | 2007-02-27 | Celgene Corporation | Methods and compositions for the prevention and treatment of atherosclerosis restenosis and related disorders |
| AU2001280804A1 (en)* | 2000-07-27 | 2002-02-13 | Eileen R. Blasi | Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| US6716829B2 (en) | 2000-07-27 | 2004-04-06 | Pharmacia Corporation | Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders |
| US6995278B2 (en) | 2000-08-18 | 2006-02-07 | Entre Med, Inc. | Antiangiogenic agents |
| US7135581B2 (en) | 2000-08-18 | 2006-11-14 | Entremed, Inc. | Antiangiogenic agents |
| US6436629B1 (en) | 2000-10-27 | 2002-08-20 | The Regents Of The University Of California | Modulating angiogenesis |
| WO2002042319A2 (en)* | 2000-11-27 | 2002-05-30 | Entremed, Inc. | 2-substituted estrogens as antiangiogenic agents |
| HUP0302732A2 (en)* | 2001-01-12 | 2003-12-29 | Société de Conseil de Recherches et d'Applications Scientifiques, S.A.S. | Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| DE10115740A1 (en) | 2001-03-26 | 2002-10-02 | Ulrich Speck | Preparation for restenosis prophylaxis |
| US6625486B2 (en) | 2001-04-11 | 2003-09-23 | Advanced Cardiovascular Systems, Inc. | Method and apparatus for intracellular delivery of an agent |
| AU4239302A (en)* | 2001-06-28 | 2003-01-02 | Pfizer Products Inc. | Benzoic acid substituted benzopyrans for the treatment of atherosclerosis |
| CN1625412A (en)* | 2002-01-30 | 2005-06-08 | 法玛西雅公司 | Combination therapy of aldosterone antagonists and non-steroidal anti-inflammatory agents for the prevention or treatment of cardiovascular diseases |
| US20050234130A1 (en)* | 2002-04-22 | 2005-10-20 | Ryozo Nagai | Medicament for therapeutic treatment of vascular disease |
| WO2004024206A1 (en)* | 2002-09-12 | 2004-03-25 | Estrogen Vascular Technology, Llc | Apparatus and method for delivering compounds to a living organism |
| DE10244847A1 (en) | 2002-09-20 | 2004-04-01 | Ulrich Prof. Dr. Speck | Medical device for drug delivery |
| US7371741B2 (en) | 2003-05-28 | 2008-05-13 | Entremed, Inc. | Estradiol derivatives and pharmaceutical compositions using same |
| US20070110785A1 (en)* | 2003-07-03 | 2007-05-17 | Eugene Tedeschi | Medical devices with proteasome inhibitors for the treatment of restenosis |
| WO2005061448A1 (en)* | 2003-12-24 | 2005-07-07 | Monash University | Compositions and methods for treating vascular conditions |
| AU2005222934B2 (en) | 2004-03-12 | 2010-06-17 | Entremed, Inc. | Antiangiogenic agents |
| US7780974B2 (en) | 2004-09-20 | 2010-08-24 | Research Development Foundation | Avicin coated stents |
| US20070134286A1 (en)* | 2004-12-02 | 2007-06-14 | Wu-Wong Jinshyun R | Methods for reducing intimal hyperplasia, smooth muscle cell proliferation and restenosis in mammals |
| US7286295B1 (en) | 2005-11-30 | 2007-10-23 | Sandia Corporation | Microoptical compound lens |
| WO2007109312A2 (en) | 2006-03-20 | 2007-09-27 | Entremed, Inc. | Disease modifying anti-arthritic activity of 2-methoxyestradiol |
| EP2356998A1 (en)* | 2010-02-17 | 2011-08-17 | Université de Liège | A pharmaceutical composition for treatment of thrombosis-related diseases comprising a fragment of prolactin (PRL)-growth hormone (GH) - placental lactogen (PL)-family protein |
| WO2011119536A1 (en) | 2010-03-22 | 2011-09-29 | Abbott Cardiovascular Systems Inc. | Stent delivery system having a fibrous matrix covering with improved stent retention |
| CN113332298A (en)* | 2021-05-27 | 2021-09-03 | 成都医学院 | New use of minocycline as a tyrosine kinase inhibitor |
| DE102024104754A1 (en) | 2024-02-21 | 2025-08-21 | Acandis Gmbh | Medical device with improved antithrombotic effect |